Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allogene Therapeutics, Inc. (ALLO) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Allogene Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1737287.
Total stock buying since 2018: $29,333,133.
Total stock sales since 2018: $149,093,458.
Total stock option exercises since 2018: $8,923,732.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 229,500 | $401,992 | 0 | $0 |
| 2024 | 1,724,327 | $5,000,680 | 36,998 | $82,315 | 0 | $0 |
| 2023 | 0 | $0 | 34,640 | $134,838 | 0 | $0 |
| 2022 | 170,039 | $2,142,491 | 130,333 | $1,468,253 | 0 | $0 |
| 2021 | 0 | $0 | 160,627 | $4,992,848 | 471,373 | $7,790,915 |
| 2020 | 146,382 | $6,879,954 | 1,904,235 | $81,315,268 | 324,743 | $737,163 |
| 2019 | 0 | $0 | 2,065,237 | $60,697,944 | 174,298 | $395,654 |
| 2018 | 850,556 | $15,310,008 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 36,885 | $52,376 | 0 | $0 |
| 2025-04 | 0 | $0 | 9,601 | $13,537 | 0 | $0 |
| 2025-03 | 0 | $0 | 52,156 | $102,307 | 0 | $0 |
| 2025-02 | 0 | $0 | 103,659 | $185,358 | 0 | $0 |
| 2025-01 | 0 | $0 | 27,199 | $48,414 | 0 | $0 |
| 2024-12 | 0 | $0 | 18,357 | $39,833 | 0 | $0 |
| 2024-06 | 0 | $0 | 18,641 | $42,482 | 0 | $0 |
| 2024-05 | 1,724,137 | $4,999,997 | 0 | $0 | 0 | $0 |
| 2024-01 | 190 | $683 | 0 | $0 | 0 | $0 |
| 2023-12 | 0 | $0 | 18,640 | $50,309 | 0 | $0 |
| 2023-08 | 0 | $0 | 10,000 | $42,859 | 0 | $0 |
| 2023-02 | 0 | $0 | 3,000 | $20,550 | 0 | $0 |
| 2023-01 | 0 | $0 | 3,000 | $21,120 | 0 | $0 |
| 2022-08 | 0 | $0 | 47,000 | $777,690 | 0 | $0 |
| 2022-07 | 0 | $0 | 2,000 | $22,880 | 0 | $0 |
| 2022-06 | 0 | $0 | 12,000 | $139,960 | 0 | $0 |
| 2022-05 | 0 | $0 | 11,500 | $85,088 | 0 | $0 |
| 2022-03 | 0 | $0 | 57,833 | $442,635 | 0 | $0 |
| 2022-01 | 170,039 | $2,142,491 | 0 | $0 | 0 | $0 |
| 2021-10 | 0 | $0 | 11,507 | $280,183 | 0 | $0 |
| 2021-09 | 0 | $0 | 10,000 | $251,544 | 5,000 | $11,350 |
| 2021-08 | 0 | $0 | 15,000 | $339,695 | 5,000 | $11,350 |
| 2021-07 | 0 | $0 | 5,000 | $107,754 | 5,000 | $11,350 |
| 2021-06 | 0 | $0 | 14,969 | $376,323 | 5,000 | $11,350 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-10 | Messemer Deborah M. (Director) | Sale | 36,885 | 1.42 | 52,376 |
| 2025-04-21 | Yoshiyama Annie (SVP, Finance) | Sale | 9,601 | 1.41 | 13,537 |
| 2025-03-14 | Beneski Benjamin Machinas (SVP, Chief Technical Officer) | Sale | 5,488 | 1.98 | 10,838 |
| 2025-03-14 | Chang David D (President and CEO) | Sale | 46,668 | 1.96 | 91,469 |
| 2025-02-18 | Messemer Deborah M. (Director) | Sale | 13,313 | 2.43 | 32,350 |
| 2025-02-03 | Roberts Zachary (EVP of R&D) | Sale | 18,832 | 1.70 | 32,014 |
| 2025-02-03 | Moore Timothy L. (Chief Technical Officer) | Sale | 14,746 | 1.71 | 25,215 |
| 2025-02-03 | Chang David D (President and CEO) | Sale | 46,003 | 1.68 | 77,285 |
| 2025-02-03 | Parker Geoffrey M. (CHIEF FINANCIAL OFFICER) | Sale | 4,361 | 1.73 | 7,544 |
| 2025-02-03 | Douglas Earl Martin (SVP, General Counsel) | Sale | 6,404 | 1.71 | 10,950 |
| 2025-01-21 | Roberts Zachary (EVP of R&D) | Sale | 27,199 | 1.78 | 48,414 |
| 2024-12-09 | Messemer Deborah M. (Director) | Sale | 9,136 | 2.18 | 19,916 |
| 2024-12-05 | Humer Franz B (Director) | Sale | 9,221 | 2.16 | 19,917 |
| 2024-06-18 | Messemer Deborah M. | Sale | 18,641 | 2.28 | 42,482 |
| 2024-05-16 | Belldegrun Arie (Director) | Buy | 1,724,137 | 2.90 | 4,999,997 |
| 2024-01-30 | Parker Geoffrey M. (CHIEF FINANCIAL OFFICER) | Buy | 190 | 3.60 | 683 |
| 2023-12-18 | Messemer Deborah M. | Sale | 18,640 | 2.70 | 50,309 |
| 2023-08-07 | Mayo Stephen | Sale | 10,000 | 4.29 | 42,859 |
| 2023-02-13 | Bhavnagri Veer (General Counsel) | Sale | 3,000 | 6.85 | 20,550 |
| 2023-01-17 | Bhavnagri Veer (General Counsel) | Sale | 3,000 | 7.04 | 21,120 |
| 2022-08-12 | Witte Owen N. (Director) | Sale | 10,000 | 17.25 | 172,500 |
| 2022-08-11 | Witte Owen N. (Director) | Sale | 20,000 | 16.50 | 330,000 |
| 2022-08-02 | Amado Rafael (EVP of R&D and CMO) | Sale | 2,000 | 11.97 | 23,940 |
| 2022-07-05 | Amado Rafael (EVP of R&D and CMO) | Sale | 2,000 | 11.44 | 22,880 |
| 2022-06-22 | Witte Owen N. | Sale | 10,000 | 11.76 | 117,600 |
| 2022-06-21 | Amado Rafael (EVP of R&D and CMO) | Sale | 2,000 | 11.18 | 22,360 |
| 2022-05-19 | Amado Rafael (EVP of R&D and CMO) | Sale | 11,500 | 7.40 | 85,088 |
| 2022-03-15 | Bhavnagri Veer (General Counsel) | Sale | 8,849 | 7.68 | 67,960 |
| 2022-03-15 | Moore Alison (Chief Technical Officer) | Sale | 8,698 | 7.63 | 66,391 |
| 2022-03-15 | Schmidt Eric Thomas (Chief Financial Officer) | Sale | 11,469 | 7.63 | 87,554 |
| 2022-03-15 | Amado Rafael (EVP of R&D and CMO) | Sale | 5,169 | 7.71 | 39,847 |
| 2022-03-15 | Chang David D (President and CEO) | Sale | 23,648 | 7.65 | 180,883 |
| 2022-01-12 | Belldegrun Arie | Buy | 155,039 | 12.60 | 1,953,491 |
| 2022-01-12 | Kazam Joshua A | Buy | 15,000 | 12.60 | 189,000 |
| 2021-10-01 | Amado Rafael (EVP of R&D and CMO) | Sale | 11,507 | 24.35 | 280,183 |
| 2021-09-15 | Bhavnagri Veer (General Counsel) | Sale | 5,000 | 24.77 | 123,844 |
| 2021-09-15 | Bhavnagri Veer (General Counsel) | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-09-09 | Witte Owen N. | Sale | 5,000 | 25.54 | 127,700 |
| 2021-08-20 | Witte Owen N. | Sale | 10,000 | 23.47 | 234,700 |
| 2021-08-16 | Bhavnagri Veer (General Counsel) | Sale | 5,000 | 21.00 | 104,995 |
| 2021-08-16 | Bhavnagri Veer (General Counsel) | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-07-15 | Bhavnagri Veer (General Counsel) | Sale | 5,000 | 21.55 | 107,754 |
| 2021-07-15 | Bhavnagri Veer (General Counsel) | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-06-15 | Bhavnagri Veer (General Counsel) | Sale | 5,000 | 25.32 | 126,600 |
| 2021-06-15 | Bhavnagri Veer (General Counsel) | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-06-09 | Witte Owen N. | Sale | 9,969 | 25.05 | 249,723 |
| 2021-05-24 | Schmidt Eric Thomas (Chief Financial Officer) | Option Ex | 14,897 | 18.22 | 271,423 |
| 2021-05-24 | Chang David D (President and CEO) | Option Ex | 27,410 | 18.22 | 499,410 |
| 2021-05-24 | Belldegrun Arie | Option Ex | 379,066 | 18.22 | 6,906,582 |
| 2021-05-18 | Bhavnagri Veer (General Counsel) | Sale | 5,000 | 30.00 | 150,000 |
| 2021-05-18 | Bhavnagri Veer (General Counsel) | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-05-17 | Bhavnagri Veer (General Counsel) | Sale | 5,000 | 28.30 | 141,475 |
| 2021-05-17 | Bhavnagri Veer (General Counsel) | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-04-15 | Bhavnagri Veer (General Counsel) | Sale | 10,000 | 32.33 | 323,270 |
| 2021-04-15 | Bhavnagri Veer (General Counsel) | Option Ex | 10,000 | 2.27 | 22,700 |
| 2021-03-15 | Bhavnagri Veer (General Counsel) | Sale | 16,623 | 38.03 | 632,239 |
| 2021-03-15 | Bhavnagri Veer (General Counsel) | Option Ex | 10,000 | 2.27 | 22,700 |
| 2021-03-15 | Moore Alison (Chief Technical Officer) | Sale | 6,164 | 38.14 | 235,088 |
| 2021-03-15 | Schmidt Eric Thomas (Chief Financial Officer) | Sale | 8,053 | 38.23 | 307,890 |
| 2021-03-15 | Amado Rafael (EVP of R&D and CMO) | Sale | 2,798 | 38.05 | 106,469 |
| 2021-03-15 | Chang David D (President and CEO) | Sale | 20,513 | 38.57 | 791,268 |
| 2021-01-15 | Schmidt Eric Thomas (Chief Financial Officer) | Sale | 15,000 | 32.46 | 486,870 |
| 2021-01-14 | Schmidt Eric Thomas (Chief Financial Officer) | Sale | 15,000 | 30.85 | 462,780 |
| 2020-12-17 | Bhavnagri Veer (General Counsel) | Option Ex | 51,500 | 2.27 | 116,905 |
| 2020-11-16 | Schmidt Eric Thomas (Chief Financial Officer) | Sale | 15,000 | 32.80 | 491,999 |
| 2020-10-15 | Schmidt Eric Thomas (Chief Financial Officer) | Sale | 15,000 | 41.24 | 618,615 |
| 2020-10-13 | Moore Alison (Chief Technical Officer) | Sale | 11,031 | 42.00 | 463,302 |
| 2020-10-13 | Moore Alison (Chief Technical Officer) | Option Ex | 11,031 | 2.27 | 25,040 |
| 2020-10-12 | Moore Alison (Chief Technical Officer) | Sale | 24,233 | 42.00 | 1,017,786 |
| 2020-10-12 | Moore Alison (Chief Technical Officer) | Option Ex | 24,233 | 2.27 | 55,008 |
| 2020-10-09 | Moore Alison (Chief Technical Officer) | Sale | 39,509 | 41.00 | 1,619,869 |
| 2020-10-09 | Moore Alison (Chief Technical Officer) | Option Ex | 30,199 | 2.27 | 68,551 |
| 2020-10-08 | Moore Alison (Chief Technical Officer) | Sale | 5,065 | 41.00 | 207,665 |
| 2020-10-08 | Moore Alison (Chief Technical Officer) | Option Ex | 5,065 | 2.27 | 11,497 |
| 2020-10-07 | Amado Rafael (EVP of R&D and CMO) | Sale | 16,538 | 39.40 | 651,514 |
| 2020-10-06 | Bhavnagri Veer (General Counsel) | Sale | 10,000 | 40.00 | 400,000 |
| 2020-10-06 | Bhavnagri Veer (General Counsel) | Option Ex | 10,000 | 2.27 | 22,700 |
| 2020-10-06 | Moore Alison (Chief Technical Officer) | Sale | 44,574 | 40.00 | 1,782,960 |
| 2020-10-06 | Moore Alison (Chief Technical Officer) | Option Ex | 35,264 | 2.27 | 80,049 |
| 2020-10-01 | Bhavnagri Veer (General Counsel) | Sale | 25,000 | 36.99 | 924,649 |
| 2020-10-01 | Bhavnagri Veer (General Counsel) | Option Ex | 25,000 | 2.27 | 56,750 |
| 2020-10-01 | Amado Rafael (EVP of R&D and CMO) | Sale | 9,752 | 36.37 | 354,660 |
| 2020-09-21 | Schmidt Eric Thomas (Chief Financial Officer) | Sale | 15,000 | 35.92 | 538,770 |
| 2020-09-01 | Bhavnagri Veer (General Counsel) | Sale | 50,000 | 35.62 | 1,780,998 |
| 2020-09-01 | Bhavnagri Veer (General Counsel) | Option Ex | 50,000 | 2.27 | 113,500 |
| 2020-08-13 | Moore Alison (Chief Technical Officer) | Option Ex | 32,451 | 2.27 | 73,663 |
| 2020-08-07 | Coulter James G | Sale | 13,291 | 37.36 | 496,538 |
| 2020-08-06 | Coulter James G | Sale | 24,154 | 37.77 | 912,393 |
| 2020-08-03 | Bhavnagri Veer (General Counsel) | Sale | 31,553 | 36.88 | 1,163,579 |
| 2020-08-03 | Bhavnagri Veer (General Counsel) | Option Ex | 25,000 | 2.27 | 56,750 |
| 2020-06-30 | Coulter James G | Sale | 59,747 | 42.21 | 2,522,040 |
| 2020-06-29 | Coulter James G | Sale | 24,904 | 43.27 | 1,077,546 |
| 2020-06-26 | Coulter James G | Sale | 500 | 44.01 | 22,005 |
| 2020-06-25 | Coulter James G | Sale | 72,359 | 44.19 | 3,197,327 |
| 2020-06-24 | Coulter James G | Sale | 15,269 | 43.93 | 670,721 |
| 2020-06-23 | Coulter James G | Sale | 132,225 | 44.11 | 5,832,180 |
| 2020-06-22 | Coulter James G | Sale | 172,425 | 42.94 | 7,404,101 |
| 2020-06-19 | Coulter James G | Sale | 47,767 | 42.04 | 2,008,315 |
| 2020-06-18 | Coulter James G | Sale | 94,600 | 42.14 | 3,986,633 |
| 2020-06-17 | Coulter James G | Sale | 87,319 | 42.18 | 3,683,464 |
| 2020-06-16 | Coulter James G | Sale | 174,511 | 42.20 | 7,364,713 |
| 2020-06-15 | Coulter James G | Sale | 129,154 | 42.14 | 5,442,937 |
| 2020-06-04 | Belldegrun Arie | Buy | 146,382 | 47.00 | 6,879,954 |
| 2020-06-04 | Coulter James G | Sale | 1,818 | 47.11 | 85,638 |
| 2020-06-03 | Coulter James G | Sale | 487,402 | 47.44 | 23,121,376 |
| 2020-03-16 | Moore Alison (Chief Technical Officer) | Sale | 3,750 | 19.20 | 71,981 |
| 2020-03-16 | Schmidt Eric Thomas (Chief Financial Officer) | Sale | 5,450 | 19.97 | 108,852 |
| 2020-03-16 | Chang David D (President and CEO) | Sale | 20,335 | 19.65 | 399,643 |
| 2019-09-18 | Moore Alison (Chief Technical Officer) | Sale | 21,067 | 32.13 | 676,882 |
| 2019-09-18 | Moore Alison (Chief Technical Officer) | Option Ex | 21,067 | 2.27 | 47,822 |
| 2019-09-17 | Moore Alison (Chief Technical Officer) | Sale | 22,503 | 32.11 | 722,571 |
| 2019-09-17 | Moore Alison (Chief Technical Officer) | Option Ex | 22,503 | 2.27 | 51,081 |
| 2019-09-16 | Moore Alison (Chief Technical Officer) | Sale | 5,257 | 32.00 | 168,234 |
| 2019-09-16 | Moore Alison (Chief Technical Officer) | Option Ex | 5,257 | 2.27 | 11,933 |
| 2019-07-30 | Moore Alison (Chief Technical Officer) | Sale | 11,819 | 29.84 | 352,738 |
| 2019-07-30 | Moore Alison (Chief Technical Officer) | Option Ex | 11,819 | 2.27 | 26,829 |
| 2019-07-29 | Moore Alison (Chief Technical Officer) | Sale | 23,815 | 29.39 | 699,875 |
| 2019-07-29 | Moore Alison (Chief Technical Officer) | Option Ex | 23,815 | 2.27 | 54,060 |
| 2019-07-26 | Moore Alison (Chief Technical Officer) | Sale | 13,193 | 29.18 | 384,998 |
| 2019-07-26 | Moore Alison (Chief Technical Officer) | Option Ex | 13,193 | 2.27 | 29,948 |
| 2019-06-28 | Moore Alison (Chief Technical Officer) | Option Ex | 27,816 | 2.27 | 63,142 |
| 2019-06-03 | Moore Alison (Chief Technical Officer) | Sale | 48,828 | 27.03 | 1,319,625 |
| 2019-06-03 | Moore Alison (Chief Technical Officer) | Option Ex | 48,828 | 2.27 | 110,839 |
| 2019-05-14 | Coulter James G | Sale | 1,918,755 | 29.38 | 56,373,021 |
| 2018-10-15 | Witte Owen N. (Director) | Buy | 15,000 | 18.00 | 270,000 |
| 2018-10-15 | Chang David D (President and CEO) | Buy | 40,000 | 18.00 | 720,000 |
| 2018-10-15 | Humer Franz B (Director) | Buy | 30,000 | 18.00 | 540,000 |
| 2018-10-15 | Belldegrun Arie (Director) | Buy | 35,000 | 18.00 | 630,000 |
| 2018-10-15 | Coulter James G | Buy | 675,000 | 18.00 | 12,150,000 |
| 2018-10-15 | Pfizer Inc (10% Owner) | Buy | 55,556 | 18.00 | 1,000,008 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALLO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Allogene Therapeutics, Inc. (symbol ALLO, CIK number 1737287) see the Securities and Exchange Commission (SEC) website.